Potyk D, Raudaskoski P
Internal Medicine Spokane, Internal Medicine Residency Program, Department of Medicine, University of Washington School of Medicine, 99220-2555, USA.
Arch Fam Med. 1998 Mar-Apr;7(2):164-73. doi: 10.1001/archfami.7.2.164.
We reviewed the approach to preoperative cardiac risk assessment, incorporating new information regarding the pathophysiologic features of perioperative myocardial ischemia and recent clinical trials. Relevant articles were identified from a MEDLINE search, followed by bibliography review of the articles identified. The multifactorial risk indexes are valuable in stratifying risks among unselected patients undergoing noncardiac surgery, but they underestimate the risks in selected groups, particularly patients with peripheral vascular disease. The preoperative evaluation of patients with coronary artery disease and risk reduction strategies for high-risk patients are considered. There are no prospective randomized clinical data comparing preoperative revascularization to intensive medical therapy and clinical decisions must be individualized. Risks particular to patients with congestive heart failure and valvular heart disease are also reviewed. Patients with congestive heart failure can undergo noncardiac surgery safely, if their cardiac disease is well-compensated. Patients with aortic stenosis have high risks, and management strategies include valve replacement, aortic valvuloplasty, and aggressive medical treatment. These modalities have not been compared prospectively, and clinical decisions must be individualized. Preoperative arrhythmias are important risk factors, although they appear to confer risk only when due to underlying heart disease. A thorough, targeted history and physical examination supplemented with judicious laboratory studies are usually sufficient to assess a patient's risk for upcoming noncardiac surgery. The clinical history should identify risk factors that predict cardiac complications, and special attention should be given to those risk factors that can be modified before surgery. New developments in perioperative medicine will likely lead to postoperative interventions to reduce silent myocardial ischemia and clinical complications.
我们回顾了术前心脏风险评估的方法,纳入了有关围手术期心肌缺血病理生理特征的新信息以及近期的临床试验。通过医学文献数据库(MEDLINE)检索确定了相关文章,随后对所确定文章的参考文献进行了回顾。多因素风险指数对于在未选择的接受非心脏手术的患者中分层风险很有价值,但它们低估了特定人群的风险,特别是外周血管疾病患者。本文考虑了冠状动脉疾病患者的术前评估以及高危患者的风险降低策略。目前尚无前瞻性随机临床数据比较术前血运重建与强化药物治疗,临床决策必须个体化。还回顾了充血性心力衰竭和瓣膜性心脏病患者特有的风险。如果充血性心力衰竭患者的心脏疾病得到良好代偿,他们可以安全地接受非心脏手术。主动脉瓣狭窄患者风险很高,管理策略包括瓣膜置换、主动脉瓣成形术和积极的药物治疗。这些方式尚未进行前瞻性比较,临床决策必须个体化。术前心律失常是重要的风险因素,尽管它们似乎仅在由潜在心脏病引起时才会带来风险。全面、有针对性的病史和体格检查辅以明智的实验室检查通常足以评估患者即将进行非心脏手术的风险。临床病史应识别预测心脏并发症的风险因素,并且应特别关注那些在手术前可以改变的风险因素。围手术期医学的新进展可能会导致术后采取干预措施以减少无症状心肌缺血和临床并发症。